ライフサイエンスコーパス: pain management

1 ioids are needed for effective postoperative pain management.

2 g alternative therapeutic target for chronic pain management.

3 oid receptor agonists represent mainstays of pain management.

4 S might be exploited as a novel approach to pain management.

5 ilitate more consistent and timely access to pain management.

6 ly relevant to both clinical diagnostics and pain management.

7 the decoding of ongoing pain sensitivity and pain management.

8 ould potentially provide a novel approach to pain management.

9 er an interdisciplinary holistic approach to pain management.

10 e and endless process, and surviving through pain management.

11 mizing therapeutic interventions for chronic pain management.

12 e concern and a challenging issue in current pain management.

13 n clinical opioid dose escalation in chronic pain management.

14 nalgesic compound and as a promising lead in pain management.

15 interventions that offer new approaches for pain management.

16 ribution makes PI16 an attractive target for pain management.

17 s present unique challenges to perioperative pain management.

18 ess of patient education in improving cancer pain management.

19 is a relative paucity of studies focused on pain management.

20 esthesia are available to help guide optimal pain management.

21 /or reduction of opioid tolerance in chronic pain management.

22 ocess aimed at developing new treatments for pain management.

23 ubtype 1.7 (Na(V)1.7), a channel targeted in pain management.

24 ds thus formulating a multimodal approach to pain management.

25 hildren for intraoperative and postoperative pain management.

26 ates are among the most prescribed drugs for pain management.

27 le interventions, underlies effective cancer pain management.

28 ic potential for target-specific neuropathic pain management.

29 effective treatments are glucose control and pain management.

30 atients were less likely to receive adequate pain management.

31 ay may provide a new therapy for neuropathic pain management.

32 e a marked impact on periprocedural care and pain management.

33 AQP1 is, thus, a novel target for pain management.

34 unintended increase in suicides due to poor pain management.

35 ders and improving opioid therapy in chronic pain management.

36 es in an effort to identify novel agents for pain management.

37 (iv) postoperative considerations including pain management.

38 and a potential neural framework for better pain management.

39 ach for their use in the context of holistic pain management.

40 s for a multimodal approach of perioperative pain management.

41 particularly in the fields of anesthesia and pain management.

42 g psychosocial treatments and disparities in pain management.

43 es for opioid prescribing and post-procedure pain management.

44 d to pain and psychosocial interventions for pain management.

45 ive and broadly applicable as strategies for pain management.

46 e phone calls on how to improve their cancer pain management.

47 ible use of POEF as an adjunct to opioids in pain management.

48 tors of GCPII thus offer a novel approach to pain management.

49 of adverse effects that limit opiate use in pain management.

50 he substitution of opioids with cannabis for pain management.

51 er total knee and total hip arthroplasty for pain management.

52 sphorylation as a potential intervention for pain management.

53 nd discuss current and future strategies for pain management.

54 ex-specific and cycle-specific approaches to pain management.

55 physical activity, and cognitive behavioral pain management.

56 cts of opioids is a major problem in chronic pain management.

57 ntial peripheral DRG targets for neuropathic pain management.

58 e considered the first line of treatment for pain management.

59 pain represents a paradigm shift in chronic pain management.

60 [63.1%]) and usually related to neuropathic pain management (224 [48.9%]).

61 analgesic recommendations for postoperative pain management, 49% received care conforming to 3 guide

62 t who performs corticosteroid injections for pain management: (a) the rationale behind corticosteroid

63 epidural analgesia as the optimal method of pain management after abdominal surgery.

64 Pain management after colorectal surgery varies widely a

65 analgesia protocols for acute postoperative pain management after colorectal surgery.

66 Recent data on techniques for pain management after pediatric ambulatory surgery will

67 urgeon prescribing and care coordination for pain management after surgery.

68 Pain management after thoracic surgery in children prese

69 Pain management after thoracic surgery is not standardiz

70 multimodal analgesics regimen for effective pain management after total knee and total hip arthropla

71 opioid interventions as part of a multimodal pain management after total knee and total hip arthropla

72 Pain management after total knee arthroplasty and total

73 rmacological interventions for postoperative pain management after total knee arthroplasty.

74 sion pathway have led to a paradigm shift in pain management, allowing clinicians to deliver personal

75 -2 (COX-2) represent an important advance in pain management, although where and when these inhibitor

76 ent standard of care for supportive care and pain management-analgesia, adjunct therapies, radiothera

77 areas, this approach could allow for better pain management and a new standard of care for the world

78 models were fitted to examine the effects of pain management and demographic and clinical factors on

79 play among addictive disease, OAT, and acute pain management and describes 4 common misconceptions re

80 The process of discussing postsurgical pain management and developing standardized opioid presc

81 nhancing gastrointestinal function recovery, pain management and early mobility.

82 physiological states including inflammation, pain management and epilepsy.

83 whereas AA patients described heterogeneous pain management and more hopeful recovery perceptions.

84 e primary drugs used in Western medicine for pain management and palliative care.

85 t a need to improve access to evidence-based pain management and to decrease excessive prescribing th

86 ic differences were found in attitudes about pain management and use of opioids.

87 hey determine therapeutic strategies such as pain management, and can underlie end-of-life decisions(

88 At diagnosis, counseling, pain management, and corticosteroids are begun.

89 considered important therapeutic targets for pain management, and development of selective antagonist

90 ive conditioning, avoiding the ICU, improved pain management, and early ambulation reduce length of s

91 ial for personalizing both acute and chronic pain management, and for designing more effective opiate

92 ection protocol targeting medication safety, pain management, and limiting external risk factors was

93 nces of FGM/C, including accurate diagnosis, pain management, and obstetric planning.

94 ist used for opioid dependence treatment and pain management, and the protease inhibitors (PIs) darun

95 s, and may thereby allow for more widespread pain management applications.

96 the transition from opioids to a multimodal pain management approach after total knee and total hip

97 An integrated pain management approach is ideally achieved by cultivat

98 Most pain clinicians believe that the pain management approach of the World Health Organizatio

99 apy is increasingly recognized as a critical pain management approach, especially when combined with

100 and rehabilitation medicine offer a range of pain management approaches that may serve as beneficial

101 Current medications used for pain management are often only partially effective, carr

102 f high-quality evidence, recommendations for pain management at the end-of-life in the ICU are homoge

103 Inadequate pain management, baseline pain severity, and certain pat

104 therapy, and referral to supportive care and pain management-be applied.

105 (deltaR) is a promising alternate target for pain management because deltaR agonists show decreased a

106 Personalized pain management begins with systematic screening, follow

107 Opioids are a mainstay of acute pain management but can have many adverse effects, contr

108 rescriptions after surgery are effective for pain management but have been a significant contributor

109 with their bodies, activity limitations, and pain management, but details of their concerns differed.

110 u-opioid receptor (MOR) to produce unrivaled pain management, but their addictive properties can lead

111 are highly effective analgesics for clinical pain management, but their misuse and abuse have led to

112 id receptor (muR), have been the mainstay of pain management, but their use is highly limited by adve

113 g noncanonical pharmacological approaches to pain management by harnessing endogenous opioids for pai

114 Promising new approaches to pain management capitalize on the brain's own mechanisms

115 ealth professionals to provide comprehensive pain management care in patients with complex needs.

116 7 secondary and tertiary care pain management centers in the United Kingdom.

117 and adopted new regulations for independent pain-management clinics.

118 ntal) or routine care (surgeon's choice) for pain management (control) over 30-days postoperatively.

119 ERAS and Pain Management CPGs were developed by a multidisciplina

120 s use race, gender, and age cues when making pain management decisions.

121 t dentists used demographic cues when making pain management decisions.

122 f VH patients' demographic cues on dentists' pain management decisions.

123 r the risk of serious infections when making pain management decisions.

124 ioid analgesics are commonly used in chronic pain management despite a potential risk of rewarding.

125 orticosteroids are frequently used in cancer pain management despite limited evidence.

126 n chronic pain patients, including implanted pain management devices, are reviewed in this study.

127 o surgical care, including informed consent, pain management, difficult diagnoses and refusal of trea

128 ary panel, composed of 13 experts in various pain management disciplines, selected by the American Pa

129 ssing pain, developing care plans related to pain management, documenting effectiveness of pain inter

130 analgesia is needed for acute postoperative pain management due to adverse effects of opioid analges

131 Strategies for appropriate pain management during and after cancer treatment should

132 ; and 5) using quality indicators to improve pain management during end-of-life in the ICU.

133 h ultrasound guidance is an integral part of pain management during the intraoperative and postoperat

134 e evidence-based information with respect to pain management during the postoperative period in order

135 the influence of patient demographic cues in pain management education is needed.

136 isseminated in conjunction with postsurgical pain management education to all ophthalmologists in the

137 This study was conducted to assess the pain management effect of the addition of steroids to a

138 tions focused largely on symptom control and pain management, effective targets for small-molecule dr

139 cluding insufficient research into nonopioid pain management, ethical lapses in corporate marketing,

140 Postoperative pain management, feeding schedule, and discharge criteri

141 provide an update on the topic of multimodal pain management for ambulatory (day-case) surgery.

142 Appropriate pain management for ambulatory surgery patients helps to

143 There is a need to explore pain management for these types of patients.

144 Pain management for traumatic rib fractures has been des

145 disability scores were 13.8 (SD 4.8) for the pain-management group and 13.3 (4.9) for the manual-ther

146 Enforcement Agency, and often recommended in pain management guidelines.

147 Technology developed for chronic pain management has been fast evolving and offers new st

148 herapy suggests the quality of pharmacologic pain management has improved.

149 oid-induced itch, a prevalent side effect of pain management, has been proposed to result from pain i

150 patient demographics, clinical history, and pain management history were retrospectively assessed.

151 Opioids are critical in pain management; however, the often-forgotten delta opio

152 American Pain Society standards for pain management in cancer recommend both pharmacologic a

153 ture search of studies investigating chronic pain management in cancer survivors.

154 Chronic pain management in children is not recognized and treate

155 an effort to better customize approaches to pain management in children.

156 aff development program, designed to improve pain management in hospitals.

157 argeted for novel therapeutic strategies for pain management in humans.

158 Pain management in opioid abusers engenders ethical and

159 Effective pain management in patients undergoing open hepatic rese

160 recent advances and findings in the field of pain management in patients undergoing thoracic surgery.

161 Opioids remain the mainstay of severe pain management in patients with cancer.

162 potential benefit of anti-IL-1 therapies for pain management in patients with chronic inflammatory di

163 ific anticonvulsants and antidepressants for pain management in patients with diabetic peripheral neu

164 a valuable role in a multimodal approach to pain management in the critically ill patient to achieve

165 re is paucity of data when it comes to acute pain management in the elderly, let alone pain resulting

166 ors specific to the injury may improve acute pain management in the future.

167 ribe evidence-based strategies for improving pain management in the ICU.

168 le to develop the patients' self-efficacy in pain management in the longer term.

169 Adapting CBT to target acute pain management in the post-operative period may impact

170 Pain management in the trauma patient can be challenging

171 These findings suggest the need for better pain management in these patients following surgery.

172 ve impairment, including the difficulties of pain management in these patients.

173 oid regulation, which increases obstacles to pain management in this population.

174 armacologic and nonpharmacologic options for pain management in this setting are reviewed.

175 d thus serve as a novel molecular target for pain management in women.

176 hat are currently employed in anesthesia and pain management include clonidine, tizanidine, and dexme

177 A paradigm shift in pain management includes early treatment of pain at the

178 tients and the various options available for pain management including utilization of nerve blocks.

179 in 2008, which showed that according to the Pain Management Index (PMI), 43.4% of patients with canc

180 The pain management index was calculated to assess treatment

181 ds and is a promising therapeutic target for pain management, inflammation, obesity, and substance ab

182 stitute, and US Army Regional Anesthesia and Pain Management Initiative.

183 correlation coefficient = 0.088), inadequate pain management (intraclass correlation coefficient = 0.

184 -cancer pain, chronic pain, persistent pain, pain management, intractable pain, and refractory pain t

185 on of a multimodal approach to perioperative pain management is advocated, including selective applic

186 Interventional pain management is an emerging specialty that uses proce

187 a national priority and effective multimodal pain management is an essential component of postoperati

188 ter surgery, suggesting focused postsurgical pain management is an opportunity to substantially impro

189 The hallmark of pain management is individualization of therapy.

190 Current pain management is limited, in particular, with regard t

191 PURPOSE OF REVIEW: Pain management is one of the most important fields in t

192 As a result, our practice of pain management is primarily limited to expert opinion a

193 Despite this issue in current clinical pain management, it remains unknown how pain influences

194 Inadequate prescription therapy pain management, lack of doctor-patient communication ab

195 The use of morphine for cancer pain management may be beneficial through its effects on

196 , and raises the possibility that optimizing pain management may resolve autonomic dysfunction in RA.

197 unds, acid suppressants, antimicrobials, and pain-management medications in paediatric patients.

198 sessment of Healthcare Providers and Systems pain management metrics.

199 ned with a particular focus on perioperative pain management, mobility, nutrition, and patient engage

200 al anesthetic/analgesic techniques and acute pain management modalities in the elderly and cognitivel

201 Acute pain management modalities offer the potential of decrea

202 endations cover physical symptom management, pain management, monitoring and documentation, psychosoc

203 However, the benefits of pain management must be weighed against the potentially

204 were randomly assigned either a programme of pain management (n=201) or manual therapy (n=201).

205 tial fluid resuscitation, end-organ support, pain management, nutrition support, and wound care are a

206 steroid (IACS) injections are often used for pain management of hip and knee OA in patients who have

207 Pain management of patients with chronic pancreatitis (C

208 hemoglobin-based oxygen-carrying solutions), pain management of severe chest trauma, surgical managem

209 variety of techniques introduced recently in pain management of the lower back.

210 Pain management of the most common surgical procedure pe

211 lf-reports and objective audits suggest that pain management optimization studies are warranted.

212 R = 2.27; 95% CI = 1.18-4.36) and inadequate pain management (OR = 2.94; 95% CI = 1.39-6.19).

213 e consumption during acupuncture may improve pain management outcomes.

214 recognized OIC as a concern but prioritized pain management over constipation.

215 nd the differences in patients' selection of pain management, over the counter (OTC) versus opioid, b

216 articipation in decision-making, adequacy of pain management, pain severity, time spent in severe pai

217 The prescribing of opioid analgesics for pain management-particularly for management of chronic n

218 o clinical care (n = 4; transitions of care, pain management, patient safety, provider competence), c

219 is prevalent among patients with cancer, yet pain management patterns in outpatient oncology are poor

220 tial to act as a beneficial adjunct agent in pain management pharmacotherapy.

221 esia implementation by anesthesiologists and pain management physicians.

222 a complex analgesic regimen for an improved pain management plan benefiting the patient population a

223 ent recommendations to support perioperative pain management plans in this population are based on a

224 ritical revisiting and modification of prior pain management practices (e.g., guidelines from the Cen

225 idence and the most current understanding of pain management practices in ICU.

226 Articles with a primary focus on nurses' pain management practices in the neonatal or paediatric

227 Changes in pain management practices remain a challenge in clinical

228 registered nurses' paediatric postoperative pain management practices were included.

229 scores, identified hospital characteristics, pain management practices, and clinical outcomes associa

230 onships between personal factors and nurses' pain management practices.

231 ient selection, nutrition, renal protection, pain management, prevention, and early detection of comp

232 of pain is the fear that medications used in pain management produce dependency, leading to diversion

233 st utility and cost effectiveness of a brief pain management program (BPM) targeting psychosocial fac

234 ds (OR 4.74), home health program (OR 2.37), pain management program [odds ratio (OR) 1.48)], increas

235 We compared the effectiveness of a brief pain-management programme with physiotherapy incorporati

236 These pain management programs are all the more appealing, giv

237 st of Latinos in various arthritis and joint pain management programs could prove to be an important

238 place drug testing, antidoping controls, and pain management programs.

239 e integration of acupuncture into mainstream pain management programs.

240 Used with proper pain management protocols, there has been a decrease in

241 Treatment includes glucocorticoid therapy, pain management, radiation therapy with or without surge

242 The WHO guidelines on cancer pain management recommend a sequential three-step analge

243 The goal is to devise a proper pain management regimen for geriatric patients with rib

244 There are challenges with pain management related to a severely ischaemic limb.

245 ted element throughout this process is acute pain management related to the surgical procedure.

246 The cornerstone of pain management remains a multimodal therapeutic strateg

247 Enhanced postoperative pain management requires dissemination of multimodal ana

248 ointments and conducted in a community-based pain management service in the United Kingdom.

249 Factors that contribute to the success of a pain management service include communication skills and

250 pain clinics can effectively deliver quality pain management services as they offer an interdisciplin

251 Current standards of care for cancer bone pain management should be applied at the onset of pain,

252 T1 may be a potential target for neuropathic pain management.SIGNIFICANCE STATEMENT In the present st

253 impact of interactions between postoperative pain management strategies and sleep apnea, as well as t

254 ectrical stimulation) as parts of multimodal pain management strategies in day-case surgery.

255 ights the importance of developing effective pain management strategies in this vulnerable population

256 opioid prescriptions associated with current pain management strategies.

257 erative cyclooxygenase-2 inhibitors in acute pain management strategies.

258 further develop comprehensive evidence-based pain management strategies.

259 t sometimes painful method, for which better pain-management strategies are needed.

260 efit from the addition of a variety of novel pain-management strategies currently under investigation

261 has implications for developing personalized pain-management strategies for chronic pain.

262 There is an unmet need for an effective pain management strategy in this group of patients.

263 e techniques, applied within a comprehensive pain management strategy, can be extremely beneficial in

264 With a more aggressive acute pain management strategy, the military has decreased acu

265 e noncanonical pharmacological approaches to pain management, such as harnessing endogenous opioids f

266 veness of a novel, theoretically based group pain management support intervention for chronic musculo

267 ility may lead to improvement in HRQoL after pain management support provided in a partnership with h

268 cal providers in managing patients with MSI; Pain Management Task Force to optimize care for wounded

269 ervention); or, 3) no nurse practitioner, no pain management team (control group).

270 intervention); 2) nurse practitioner but no pain management team (partial intervention); or, 3) no n

271 a nurse practitioner-led, inter-professional pain management team in LTC in improving (a) pain-relate

272 as used to evaluate a nurse practitioner-led pain management team, including both a quantitative and

273 Brief pain management techniques delivered by appropriately tr

274 also discuss some recent findings regarding pain management techniques in children particularly the

275 research is needed to explore innovations in pain management that take into account limited resource

276 chronic calcifying pancreatitis, focusing on pain management, the role of endoscopic and surgical int

277 alternatives to NSAIDs (such as opioids) for pain management, the use of NSAIDs is likely to rise.

278 Contemporary pain management theories and models also suggest that a

279 nus 6 months) were examined for relevance to pain management therapeutics.

280 der scrutiny as a pharmacological target for pain management therapies.

281 Pain management therapy, including regional anesthesia,

282 aOR) heteromer as a credible novel target in pain management therapy.

283 ialists worked together to achieve effective pain management, they enacted and inter-acted in the rol

284 traditionally been the cornerstone of acute pain management, they have potential negative effects ra

285 o provide all clinical services asked except pain management; this included obstetric care (23.7% vs

286 Older patients will need more careful pain management to achieve the same results as younger p

287 focus on optimizing nutrition, mobility, and pain management to minimize adverse events after surgica

288 The quality of pain management training during medical school and resid

289 potential therapeutic use of DOR agonists in pain management under chronic opioid conditions.

290 ovel methods to improve current opioid-based pain management via inhibition of glial TLR4 and illustr

291 c regression analysis showed that inadequate pain management was significantly associated with pain d

292 cological treatment protocol for neuropathic pain management, was reported to selectively reduce the

293 To assist cancer centers in improving pain management, we conducted a systematic review of ins

294 The most important barriers to pain management were poor assessment (median, 6; IQR, 4

295 ality were in the areas of goals of care and pain management while lowest levels were for legal issue

296 rapies, and next-generation alternatives for pain management will be discussed.

297 ight sleep as a novel therapeutic target for pain management within and outside the clinic, including

298 EDA is mainstay of multimodal pain management within enhanced recovery pathways [enhan

299 Pain management would be greatly enhanced by a formulati

300 tion is a significant burden associated with pain management, yet its precise underlying mechanism an